Highstreet Asset Management’s United Therapeutics UTHR Stock Holding History

Highstreet Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$338K	Buy	+3,834	New	+$337K	0.02%	421
2016 Q1	–	Sell	-3,271	Closed	-$512K	–	190
2015 Q4	$512K	Buy	+3,271	New	+$476K	0.11%	153
2014 Q1	–	Sell	-7,250	Closed	-$820K	–	131
2013 Q4	$820K	Hold	7,250	–	–	0.17%	112
2013 Q3	$572K	Hold	7,250	–	–	0.12%	113
2013 Q2	$477K	Buy	+7,250	New	+$467K	0.1%	119

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Highstreet Asset Management's UTHR Position: Q4 2019 in Review

Highstreet Asset Management opened a new position in United Therapeutics (UTHR) in Q4 2019: 3,834 shares worth $338K. The stake represents 0.02% of the portfolio and ranks #421 among its holdings. This is a return to the name: Highstreet Asset Management previously reported a position in UTHR as recently as Q4 2015.

Highstreet Asset Management first reported a position in UTHR in Q2 2013 and has held it in 5 quarters since. The position peaked at $820K in Q4 2013. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

Highstreet Asset Management held 3,834 shares of United Therapeutics worth $338K as of Q4 2019.
United Therapeutics was a new Highstreet Asset Management position in Q4 2019.
United Therapeutics made up 0.02% of Highstreet Asset Management's portfolio in Q4 2019, its #421 holding.
Highstreet Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 5 quarters since.
Highstreet Asset Management's United Therapeutics position peaked at $820K in Q4 2013.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.